MVASI (BEVACIZUMAB-AWWB) — FDA Approval BLA761028 (AMGEN INC)
MVASI (BEVACIZUMAB-AWWB) — FDA Approval BLA761028 (AMGEN INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: MVASI; Active ingredients: BEVACIZUMAB-AWWB; Application number: BLA761028.
| Brand name | MVASI |
|---|---|
| Active ingredients | BEVACIZUMAB-AWWB |
| Application number | BLA761028 |
| Sponsor | AMGEN INC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20170914 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →